| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06191
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-10 |
| filingDate |
2003-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6689802c1552483b584741783711b85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd6f3fbac802b1f2fdced9343362d06c |
| publicationDate |
2003-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003166580-A1 |
| titleOfInvention |
Substituted amino carboxamides for the treatment of alzheimer's disease |
| abstract |
The present invention relates to compounds of formula (I): n n n useful in treating Alzheimer's disease and other similar diseases. These compounds include inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal. The compounds of the invention are useful in pharmaceutical compositions and methods of treatment to reduce A beta peptide formation. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007173521-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7872009-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7838676-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8552181-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7745484-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8163766-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8173810-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8163909-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8633315-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7973047-B2 |
| priorityDate |
2002-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |